NEW DELHI: Shares of Dr. Reddy's Laboratories Ltd. traded 1.97 per cent down in Monday 's trade at 10:35AM (IST). Around 15321 shares changed hands on the counter.
The stock opened at Rs 4000.0 and touched an intraday high and low of Rs 4000.0 and Rs 3860.5 , respectively, in the session so far. The stock quoted a 52-week high of Rs 4099.9 and a 52-week low of Rs 2352.0 .
Market cap of the company stood at Rs 65021.47 crore on May 11.
Drug major Dr Reddy's Laboratories is recalling 1,752 bottles of generic heartburn medicine in the US after the American health regulator found quality issues with the product.
Key Financials
The company reported consolidated net sales of Rs 4383.8 crore for the quarter ended 31-Dec-2019 , down -8.69 per cent from previous quarter's Rs 4800.8 crore and down 15.79 per cent from the year-ago quarter's Rs 3786.1 crore.
Shareholding pattern
As of 31-Mar-2020 , DIIs held 7.18 per cent stake in the firm , while foreign institutional investors held 30.15 per cent and the promoters 26.75 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 38.24 and a price-to-book ratio of 4.63 . A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Dr. Reddy's Laboratories Ltd. belongs to the Pharma - Indian industry.